ICAGEN INC·4

Feb 10, 1:52 PM ET

ICAGEN INC 4

4 · ICAGEN INC · Filed Feb 10, 2005

Insider Transaction Report

Form 4
Period: 2005-02-08
Transactions
  • Conversion

    Common Stock

    2005-02-08+157,186509,361 total
  • Conversion

    Common Stock

    2005-02-08+325,000352,175 total
  • Conversion

    Series C Convertible Preferred Stock

    2005-02-0869,0840 total
    Common Stock (69,084 underlying)
  • Conversion

    Common Stock

    2005-02-08+69,08469,084 total
  • Conversion

    Series A Convertible Preferred Stock

    2005-02-08325,0000 total
    Common Stock (325,000 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2005-02-08157,1860 total
    Common Stock (157,186 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2005-02-08291,8030 total
    Common Stock (291,803 underlying)
  • Conversion

    Common Stock

    2005-02-08+291,803311,395 total
Footnotes (4)
  • [F1]Upon the closing of the Issuer's public offering, the Series A, Series B and Series C Convertible Preferred Stock converted on a 1-for-1 basis into Common Stock.
  • [F2]Shares are owned by Medical Science Partners II, L.P.
  • [F3]Shares are owned by Medical Science II Co-Investment, L.P.
  • [F4]These shares were immediately exercisable. They had no expiration date.

Documents

2 files